196 related articles for article (PubMed ID: 29802484)
1. Characterization of the trigeminovascular actions of several adenosine A
Haanes KA; Labastida-Ramírez A; Chan KY; de Vries R; Shook B; Jackson P; Zhang J; Flores CM; Danser AHJ; Villalón CM; MaassenVanDenBrink A
J Headache Pain; 2018 May; 19(1):41. PubMed ID: 29802484
[TBL] [Abstract][Full Text] [Related]
2. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.
Chan KY; Gupta S; de Vries R; Danser AH; Villalón CM; Muñoz-Islas E; Maassenvandenbrink A
Br J Pharmacol; 2010 Jul; 160(6):1316-25. PubMed ID: 20590623
[TBL] [Abstract][Full Text] [Related]
3. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
4. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
[TBL] [Abstract][Full Text] [Related]
5. Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery - potential antimigraine efficacy.
Labastida-Ramírez A; Rubio-Beltrán E; Haanes KA; de Vries R; Dammers R; Bogers AJJC; van den Bogaerdt A; Daugherty BL; Danser AHJ; Villalón CM; MaassenVanDenBrink A
J Headache Pain; 2019 May; 20(1):47. PubMed ID: 31053059
[TBL] [Abstract][Full Text] [Related]
6. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
7. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
[TBL] [Abstract][Full Text] [Related]
8. The role of histamine in dural vessel dilation.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Brain Res; 2002 Nov; 956(1):96-102. PubMed ID: 12426051
[TBL] [Abstract][Full Text] [Related]
9. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
[TBL] [Abstract][Full Text] [Related]
10. Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat.
Honey AC; Bland-Ward PA; Connor HE; Feniuk W; Humphrey PP
Cephalalgia; 2002 May; 22(4):260-4. PubMed ID: 12100087
[TBL] [Abstract][Full Text] [Related]
11. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
[TBL] [Abstract][Full Text] [Related]
13. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels.
Akerman S; Williamson DJ; Kaube H; Goadsby PJ
Eur J Pharmacol; 2002 Oct; 452(2):223-8. PubMed ID: 12354573
[TBL] [Abstract][Full Text] [Related]
14. CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.
Zeller J; Poulsen KT; Sutton JE; Abdiche YN; Collier S; Chopra R; Garcia CA; Pons J; Rosenthal A; Shelton DL
Br J Pharmacol; 2008 Dec; 155(7):1093-103. PubMed ID: 18776916
[TBL] [Abstract][Full Text] [Related]
15. The role of dopamine in a model of trigeminovascular nociception.
Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):162-9. PubMed ID: 15778266
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats.
Zeraati M; Mirnajafi-Zadeh J; Fathollahi Y; Namvar S; Rezvani ME
Seizure; 2006 Jan; 15(1):41-8. PubMed ID: 16337818
[TBL] [Abstract][Full Text] [Related]
17. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
18. The effect of adrenergic compounds on neurogenic dural vasodilatation.
Akerman S; Williamson DJ; Hill RG; Goadsby PJ
Eur J Pharmacol; 2001 Jul; 424(1):53-8. PubMed ID: 11470260
[TBL] [Abstract][Full Text] [Related]
19. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
[TBL] [Abstract][Full Text] [Related]
20. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
Prior HM; Yates MS; Beech DJ
Br J Pharmacol; 1999 Jan; 126(2):494-500. PubMed ID: 10077243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
